What is Dadi?
Dadi operates as the leading male fertility company, aiming to democratize fertility testing and cryogenic sperm storage. The company offers an at-home collection kit and storage solution that is FDA-licensed across all 50 U.S. states. Dadi's service addresses the systemic issue of male factor infertility, which has historically received inadequate attention in reproductive healthcare. By providing a faster, easier, and more cost-effective alternative to traditional sperm banks, Dadi empowers men and couples to make informed decisions about fertility preservation and family building. Founded in Brooklyn, New York, by Tom Smith, Gordon von Steiner, and Mackey Saturday in January 2019, Dadi has expanded its reach to customers in over 1,100 cities nationwide.
How much funding has Dadi raised?
Dadi has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2019): $5M with participation from Alex Chung, TCG, Nat Turner, Third Kind Ventures, and firstminute Capital
Key Investors in Dadi
Alex Chung
Alex Chung is an individual investor participating in the company's funding round.
TCG
TCG is an investment entity that has provided backing to Dadi.
Nat Turner
Nat Turner is an individual investor contributing to Dadi's growth.
What's next for Dadi?
With the recent major strategic investment, Dadi is poised for accelerated growth and expansion of its services. This enterprise-level funding is expected to fuel further innovation in male fertility diagnostics and preservation technologies. The company's focus on affordability and accessibility, combined with its comprehensive at-home solution, positions it to capture a significant share of the burgeoning fertility market. Future developments may include enhanced diagnostic capabilities, broader geographic reach, and strategic partnerships within the broader reproductive health ecosystem.
See full Dadi company page
